Skip to content

Drug interactions

Glycopyrronium tosylate + Ipratropium-salbutamol

Severity: Minor

Glycopyrronium tosylate and Ipratropium-salbutamol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Topical glycopyrronium tosylate (used for axillary hyperhidrosis) is labeled to warn against use with other anticholinergics because of additive effects. Systemic absorption is limited, but inhaled ipratropium may add to dry mouth, urinary hesitancy or blurred vision.

What this interaction means in plain words

Glycopyrronium tosylate and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Additive antimuscarinic effects, with limited systemic exposure from both agents.

What to do

No routine change is needed; ask the patient about anticholinergic symptoms such as urinary retention or visual blurring and stop the topical product if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glycopyrronium tosylate and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glycopyrronium tosylate with Ipratropium-salbutamol?

MediHelp rates the interaction as minor. Glycopyrronium tosylate and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Topical glycopyrronium tosylate (used for axillary hyperhidrosis) is labeled to warn against use with other anticholinergics because of additive effects. Systemic absorption is limited, but inhaled ipratropium may add to dry mouth, urinary hesitancy or blurred vision.

How serious is the interaction between Glycopyrronium tosylate and Ipratropium-salbutamol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; ask the patient about anticholinergic symptoms such as urinary retention or visual blurring and stop the topical product if they occur.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in